ID P49792; PN E3 SUMO-protein ligase RanBP2; GN RANBP2; OS 9606; SL Nucleus Position: SL-0178; SL Nucleus Position: SL-0182; SL Nucleus Position: SL-0185; SL Comments: Nucleus {ECO:0000269|PubMed:7775481}. Nucleus membrane {ECO:0000269|PubMed:11839768}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7603572}. Nucleus envelope {ECO:0000269|PubMed:20386726}. Note=Detected in diffuse and discrete intranuclear foci (PubMed:11839768). Cytoplasmic filaments (PubMed:7775481). {ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:7775481}. DR UNIPROT: P49792; DR UNIPROT: Q13074; DR UNIPROT: Q15280; DR UNIPROT: Q53TE2; DR UNIPROT: Q59FH7; DR PDB: 1RRP; DR PDB: 1XKE; DR PDB: 1Z5S; DR PDB: 2LAS; DR PDB: 3UIN; DR PDB: 3UIO; DR PDB: 3UIP; DR PDB: 4GA0; DR PDB: 4I9Y; DR PDB: 4L6E; DR PDB: 4LQW; DR PDB: 5CLL; DR PDB: 5CLQ; DR Pfam: PF12185; DR Pfam: PF00160; DR Pfam: PF00638; DR Pfam: PF00641; DR PROSITE: PS00170; DR PROSITE: PS50072; DR PROSITE: PS50196; DR PROSITE: PS50005; DR PROSITE: PS50293; DR PROSITE: PS01358; DR PROSITE: PS50199; DR OMIM: 601181; DR OMIM: 608033; DR DisGeNET: 5903; DE Function: E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:22194619, PubMed:15931224). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. DE Disease: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815, ECO:0000269|PubMed:34400285}. Note=The disease is caused by variants affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}. Note=A chromosomal aberration involving RANBP2 is a cause of chromosome 8p11 myeloproliferative syndrome. Translocation t(2;8)(q12;p11) with FGFR1. Chromosome 8p11 myeloproliferative syndrome is characterized by myeloid hyperplasia, eosinophilia and T-cell or B- cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. {ECO:0000269|PubMed:23041776}. DE Reference Proteome: Yes; DE Interaction: O14524; IntAct: EBI-21695903; Score: 0.35 DE Interaction: P04626; IntAct: EBI-4373195; Score: 0.46 DE Interaction: P46060; IntAct: EBI-21928721; Score: 0.62 DE Interaction: P49790; IntAct: EBI-11076796; Score: 0.35 DE Interaction: O60260; IntAct: EBI-973169; Score: 0.64 DE Interaction: P63279; IntAct: EBI-11105225; Score: 0.75 DE Interaction: P02768; IntAct: EBI-1224020; Score: 0.35 DE Interaction: P01106; IntAct: EBI-1237540; Score: 0.35 DE Interaction: P11388; IntAct: EBI-1773456; Score: 0.40 DE Interaction: Q01320; IntAct: EBI-1775292; Score: 0.40 DE Interaction: P03116; IntAct: EBI-7414341; Score: 0.40 DE Interaction: P33176; IntAct: EBI-8602425; Score: 0.40 DE Interaction: Q9Z0E3; IntAct: EBI-2549710; Score: 0.35 DE Interaction: Q9ERU9; IntAct: EBI-2555617; Score: 0.40 DE Interaction: Q9QWT9; IntAct: EBI-2558911; Score: 0.40 DE Interaction: Q07832; IntAct: EBI-2560950; Score: 0.40 DE Interaction: Q5NET2; IntAct: EBI-2801802; Score: 0.00 DE Interaction: Q81LI7; IntAct: EBI-2823809; Score: 0.00 DE Interaction: A0A380PEL1; IntAct: EBI-2841285; Score: 0.00 DE Interaction: Q0WCK7; IntAct: EBI-2842408; Score: 0.00 DE Interaction: A0A380PDY1; IntAct: EBI-2856426; Score: 0.00 DE Interaction: Q13573; IntAct: EBI-7950968; Score: 0.35 DE Interaction: Q99459; IntAct: EBI-7954144; Score: 0.35 DE Interaction: Q9GZQ8; IntAct: EBI-3045543; Score: 0.35 DE Interaction: P60520; IntAct: EBI-3046676; Score: 0.35 DE Interaction: P25054; IntAct: EBI-3437454; Score: 0.00 DE Interaction: Q12802; IntAct: EBI-3449822; Score: 0.00 DE Interaction: Q4LE39; IntAct: EBI-3449836; Score: 0.00 DE Interaction: Q9Y613; IntAct: EBI-3449871; Score: 0.00 DE Interaction: P30533; IntAct: EBI-3449926; Score: 0.00 DE Interaction: P21675; IntAct: EBI-3450016; Score: 0.00 DE Interaction: Q96RY7; IntAct: EBI-3450063; Score: 0.00 DE Interaction: P49792; IntAct: EBI-3450084; Score: 0.00 DE Interaction: P52292; IntAct: EBI-3931429; Score: 0.37 DE Interaction: Q13616; IntAct: EBI-3933504; Score: 0.37 DE Interaction: P62826; IntAct: EBI-3933494; Score: 0.76 DE Interaction: Q14324; IntAct: EBI-5661299; Score: 0.00 DE Interaction: Q53GG5; IntAct: EBI-5662564; Score: 0.00 DE Interaction: O15169; IntAct: EBI-6169699; Score: 0.35 DE Interaction: P05919; IntAct: EBI-6176256; Score: 0.35 DE Interaction: Q9UBU9; IntAct: EBI-6262548; Score: 0.53 DE Interaction: Q9UBE8; IntAct: EBI-6381385; Score: 0.35 DE Interaction: Q13617; IntAct: EBI-21327106; Score: 0.35 DE Interaction: Q5S007; IntAct: EBI-6515052; Score: 0.53 DE Interaction: Q8WYP5; IntAct: EBI-9050350; Score: 0.40 DE Interaction: Q13043; IntAct: EBI-10049645; Score: 0.35 DE Interaction: Q72497; IntAct: EBI-9943756; Score: 0.44 DE Interaction: Q99853; IntAct: EBI-11317404; Score: 0.35 DE Interaction: Q12952; IntAct: EBI-11318689; Score: 0.35 DE Interaction: Q9C009; IntAct: EBI-11319301; Score: 0.35 DE Interaction: P05412; IntAct: EBI-11323169; Score: 0.35 DE Interaction: P03220; IntAct: EBI-11722152; Score: 0.35 DE Interaction: Q2MG95; IntAct: EBI-11733653; Score: 0.35 DE Interaction: Q6PFD9; IntAct: EBI-10994876; Score: 0.35 DE Interaction: Q9Z1B5; IntAct: EBI-10996176; Score: 0.35 DE Interaction: Q8BH74; IntAct: EBI-10997196; Score: 0.35 DE Interaction: Q99P88; IntAct: EBI-10997466; Score: 0.35 DE Interaction: E9PUA5; IntAct: EBI-10999661; Score: 0.35 DE Interaction: Q80U93; IntAct: EBI-11014856; Score: 0.35 DE Interaction: Q8VE37; IntAct: EBI-11043815; Score: 0.35 DE Interaction: P63280; IntAct: EBI-11044140; Score: 0.35 DE Interaction: Q9BVL2; IntAct: EBI-11077390; Score: 0.35 DE Interaction: E9Q3P4; IntAct: EBI-11086604; Score: 0.35 DE Interaction: Q96EE3; IntAct: EBI-11086798; Score: 0.35 DE Interaction: Q14974; IntAct: EBI-11115566; Score: 0.35 DE Interaction: P57740; IntAct: EBI-11160436; Score: 0.35 DE Interaction: Q8IWL3; IntAct: EBI-13943458; Score: 0.35 DE Interaction: P18754; IntAct: EBI-21567271; Score: 0.35 DE Interaction: P61769; IntAct: EBI-21675069; Score: 0.35 DE Interaction: Q9BXS6; IntAct: EBI-21691494; Score: 0.35 DE Interaction: Q9Y228; IntAct: EBI-21696444; Score: 0.35 DE Interaction: Q8IYT4; IntAct: EBI-16421609; Score: 0.35 DE Interaction: P70168; IntAct: EBI-15732742; Score: 0.36 DE Interaction: Q921C5; IntAct: EBI-15847872; Score: 0.63 DE Interaction: Q8TD16; IntAct: EBI-15847951; Score: 0.40 DE Interaction: Q6ZNJ1; IntAct: EBI-16749633; Score: 0.35 DE Interaction: Q15628; IntAct: EBI-20737473; Score: 0.35 DE Interaction: P10809; IntAct: EBI-20901016; Score: 0.40 DE Interaction: Q8N9W5; IntAct: EBI-20913366; Score: 0.40 DE Interaction: Q92878; IntAct: EBI-20918244; Score: 0.40 DE Interaction: Q6P4A8; IntAct: EBI-20931312; Score: 0.40 DE Interaction: A2A935; IntAct: EBI-21022882; Score: 0.35 DE Interaction: P14404; IntAct: EBI-21026252; Score: 0.35 DE Interaction: Q9Y275; IntAct: EBI-21266480; Score: 0.35 DE Interaction: O00213; IntAct: EBI-21017901; Score: 0.35 DE Interaction: P03372; IntAct: EBI-21301141; Score: 0.35 DE Interaction: O00499; IntAct: EBI-21385533; Score: 0.00 DE Interaction: Q5NHH2; IntAct: EBI-22299104; Score: 0.37 DE Interaction: P11234; IntAct: EBI-25376255; Score: 0.35 DE Interaction: P83105; IntAct: EBI-25745135; Score: 0.35 DE Interaction: Q9C0B5; IntAct: EBI-25636144; Score: 0.35 DE Interaction: Q9Y5P2; IntAct: EBI-26354638; Score: 0.35 DE Interaction: P42685; IntAct: EBI-28935169; Score: 0.35 DE Interaction: P53350; IntAct: EBI-28938281; Score: 0.35 DE Interaction: Q86UX6; IntAct: EBI-28942129; Score: 0.35 DE Interaction: Q96GD4; IntAct: EBI-28944360; Score: 0.35 DE Interaction: Q9Y6S9; IntAct: EBI-28948011; Score: 0.35 DE Interaction: Q92630; IntAct: EBI-28952196; Score: 0.27 DE Interaction: Q05D32; IntAct: EBI-27113232; Score: 0.35 DE Interaction: O15297; IntAct: EBI-27113880; Score: 0.35 DE Interaction: Q13283; IntAct: EBI-28955349; Score: 0.35 DE Interaction: Q07866; IntAct: EBI-30822114; Score: 0.44 DE Interaction: P63165; IntAct: EBI-30826718; Score: 0.44 GO GO:0005642; GO GO:0005737; GO GO:0005829; GO GO:0043231; GO GO:0016020; GO GO:0005635; GO GO:0042405; GO GO:0031965; GO GO:0005643; GO GO:0044614; GO GO:0044615; GO GO:0005654; GO GO:0106068; GO GO:0046872; GO GO:0003723; GO GO:0031267; GO GO:0061665; GO GO:0019789; GO GO:0051642; GO GO:0051028; GO GO:0006607; GO GO:0051168; GO GO:0006913; GO GO:0033133; GO GO:0006457; GO GO:0000413; GO GO:0016925; GO GO:0006111; TP Membrane Topology: Unknown; Source: UniProt - Sequence Analysis; SQ MRRSKADVERYIASVQGSTPSPRQKSMKGFYFAKLYYEAKEYDLAKKYICTYINVQERDPKAHRFLGLLYELEENTDKAV SQ ECYRRSVELNPTQKDLVLKIAELLCKNDVTDGRAKYWLERAAKLFPGSPAIYKLKEQLLDCEGEDGWNKLFDLIQSELYV SQ RPDDVHVNIRLVEVYRSTKRLKDAVAHCHEAERNIALRSSLEWNSCVVQTLKEYLESLQCLESDKSDWRATNTDLLLAYA SQ NLMLLTLSTRDVQESRELLQSFDSALQSVKSLGGNDELSATFLEMKGHFYMHAGSLLLKMGQHSSNVQWRALSELAALCY SQ LIAFQVPRPKIKLIKGEAGQNLLEMMACDRLSQSGHMLLNLSRGKQDFLKEIVETFANKSGQSALYDALFSSQSPKDTSF SQ LGSDDIGNIDVREPELEDLTRYDVGAIRAHNGSLQHLTWLGLQWNSLPALPGIRKWLKQLFHHLPHETSRLETNAPESIC SQ ILDLEVFLLGVVYTSHLQLKEKCNSHHSSYQPLCLPLPVCKQLCTERQKSWWDAVCTLIHRKAVPGNVAKLRLLVQHEIN SQ TLRAQEKHGLQPALLVHWAECLQKTGSGLNSFYDQREYIGRSVHYWKKVLPLLKIIKKKNSIPEPIDPLFKHFHSVDIQA SQ SEIVEYEEDAHITFAILDAVNGNIEDAVTAFESIKSVVSYWNLALIFHRKAEDIENDALSPEEQEECKNYLRKTRDYLIK SQ IIDDSDSNLSVVKKLPVPLESVKEMLNSVMQELEDYSEGGPLYKNGSLRNADSEIKHSTPSPTRYSLSPSKSYKYSPKTP SQ PRWAEDQNSLLKMICQQVEAIKKEMQELKLNSSNSASPHRWPTENYGPDSVPDGYQGSQTFHGAPLTVATTGPSVYYSQS SQ PAYNSQYLLRPAANVTPTKGPVYGMNRLPPQQHIYAYPQQMHTPPVQSSSACMFSQEMYGPPALRFESPATGILSPRGDD SQ YFNYNVQQTSTNPPLPEPGYFTKPPIAAHASRSAESKTIEFGKTNFVQPMPGEGLRPSLPTQAHTTQPTPFKFNSNFKSN SQ DGDFTFSSPQVVTQPPPAAYSNSESLLGLLTSDKPLQGDGYSGAKPIPGGQTIGPRNTFNFGSKNVSGISFTENMGSSQQ SQ KNSGFRRSDDMFTFHGPGKSVFGTPTLETANKNHETDGGSAHGDDDDDGPHFEPVVPLPDKIEVKTGEEDEEEFFCNRAK SQ LFRFDVESKEWKERGIGNVKILRHKTSGKIRLLMRREQVLKICANHYISPDMKLTPNAGSDRSFVWHALDYADELPKPEQ SQ LAIRFKTPEEAALFKCKFEEAQSILKAPGTNVAMASNQAVRIVKEPTSHDNKDICKSDAGNLNFEFQVAKKEGSWWHCNS SQ CSLKNASTAKKCVSCQNLNPSNKELVGPPLAETVFTPKTSPENVQDRFALVTPKKEGHWDCSICLVRNEPTVSRCIACQN SQ TKSANKSGSSFVHQASFKFGQGDLPKPINSDFRSVFSTKEGQWDCSACLVQNEGSSTKCAACQNPRKQSLPATSIPTPAS SQ FKFGTSETSKTLKSGFEDMFAKKEGQWDCSSCLVRNEANATRCVACQNPDKPSPSTSVPAPASFKFGTSETSKAPKSGFE SQ GMFTKKEGQWDCSVCLVRNEASATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEA SQ SATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQCPSKQNQTTAIS SQ TPASSEISKAPKSGFEGMFIRKGQWDCSVCCVQNESSSLKCVACDASKPTHKPIAEAPSAFTLGSEMKLHDSSGSQVGTG SQ FKSNFSEKASKFGNTEQGFKFGHVDQENSPSFMFQGSSNTEFKSTKEGFSIPVSADGFKFGISEPGNQEKKSEKPLENGT SQ GFQAQDISGQKNGRGVIFGQTSSTFTFADLAKSTSGEGFQFGKKDPNFKGFSGAGEKLFSSQYGKMANKANTSGDFEKDD SQ DAYKTEDSDDIHFEPVVQMPEKVELVTGEEDEKVLYSQRVKLFRFDAEVSQWKERGLGNLKILKNEVNGKLRMLMRREQV SQ LKVCANHWITTTMNLKPLSGSDRAWMWLASDFSDGDAKLEQLAAKFKTPELAEEFKQKFEECQRLLLDIPLQTPHKLVDT SQ GRAAKLIQRAEEMKSGLKDFKTFLTNDQTKVTEEENKGSGTGAAGASDTTIKPNPENTGPTLEWDNYDLREDALDDSVSS SQ SSVHASPLASSPVRKNLFRFGESTTGFNFSFKSALSPSKSPAKLNQSGTSVGTDEESDVTQEEERDGQYFEPVVPLPDLV SQ EVSSGEENEQVVFSHRAKLYRYDKDVGQWKERGIGDIKILQNYDNKQVRIVMRRDQVLKLCANHRITPDMTLQNMKGTER SQ VWLWTACDFADGERKVEHLAVRFKLQDVADSFKKIFDEAKTAQEKDSLITPHVSRSSTPRESPCGKIAVAVLEETTRERT SQ DVIQGDDVADATSEVEVSSTSETTPKAVVSPPKFVFGSESVKSIFSSEKSKPFAFGNSSATGSLFGFSFNAPLKSNNSET SQ SSVAQSGSESKVEPKKCELSKNSDIEQSSDSKVKNLFASFPTEESSINYTFKTPEKAKEKKKPEDSPSDDDVLIVYELTP SQ TAEQKALATKLKLPPTFFCYKNRPDYVSEEEEDDEDFETAVKKLNGKLYLDGSEKCRPLEENTADNEKECIIVWEKKPTV SQ EEKAKADTLKLPPTFFCGVCSDTDEDNGNGEDFQSELQKVQEAQKSQTEEITSTTDSVYTGGTEVMVPSFCKSEEPDSIT SQ KSISSPSVSSETMDKPVDLSTRKEIDTDSTSQGESKIVSFGFGSSTGLSFADLASSNSGDFAFGSKDKNFQWANTGAAVF SQ GTQSVGTQSAGKVGEDEDGSDEEVVHNEDIHFEPIVSLPEVEVKSGEEDEEILFKERAKLYRWDRDVSQWKERGVGDIKI SQ LWHTMKNYYRILMRRDQVFKVCANHVITKTMELKPLNVSNNALVWTASDYADGEAKVEQLAVRFKTKEVADCFKKTFEEC SQ QQNLMKLQKGHVSLAAELSKETNPVVFFDVCADGEPLGRITMELFSNIVPRTAENFRALCTGEKGFGFKNSIFHRVIPDF SQ VCQGGDITKHDGTGGQSIYGDKFEDENFDVKHTGPGLLSMANQGQNTNNSQFVITLKKAEHLDFKHVVFGFVKDGMDTVK SQ KIESFGSPKGSVCRRITITECGQI //